��������

Michael Chambers co-founded Aldevron in 1998, holding the position of President and CEO until this year. He is now Chairman of its Board. Using a technology platform that he co-invented, Aldevron started producing plasmid DNA for biotech researchers in a small lab on the campus of North Dakota State University (NDSU) in Fargo, ND. He and his co-founder built what is today considered the industry’s leading and most respected contract manufacturing organizations in the world. The company utilizes industry-enabling technologies to make recombinant products including nucleic acids, gene editing enzymes, proteins and antibodies. Exemplifying ongoing success, an additional manufacturing plant of 190,000 square-feet building is under construction. In recognition of his significant contributions to the industry, Chambers was named as one of the “100 Most Intriguing Entrepreneurs” by Goldman Sachs in 2018. He received Bachelor of Science degrees in biotechnology, chemistry, and microbiology from NDSU.